Traws Pharma, Inc. — Director's Dealing 2018

Jul 30, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2018-07-26

Reporting Person: Kumar Ramesh (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-26	Stock Option (right to purchase)	$0.46	A	1065600	Acquired	2028-07-26	Common Stock (1065600)	Direct

Footnotes

F1: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.